BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
Authors
Keywords
HIF pathway inhibition, Cisplatin, Fractionated radiation, Local tumor control, Tumor microenvironment, Human tumor xenograft
Journal
Radiation Oncology
Volume 9, Issue 1, Pages 207
Publisher
Springer Nature
Online
2014-09-19
DOI
10.1186/1748-717x-9-207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-Inducible Factor Pathway Inhibition Resolves Tumor Hypoxia and Improves Local Tumor Control After Single-Dose Irradiation
- (2013) Linda Helbig et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PERK/eIF2 signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS
- (2013) K. M. Rouschop et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycolysis-related gene induction and ATP reduction during fractionated irradiation
- (2013) K. Goetze et al. STRAHLENTHERAPIE UND ONKOLOGIE
- HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
- (2012) Yanbin Liu et al. CARCINOGENESIS
- Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
- (2012) T. W. H. Meijer et al. CLINICAL CANCER RESEARCH
- Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck
- (2012) Jay S. Cooper et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- HIF1-Alpha Expression Predicts Survival of Patients with Squamous Cell Carcinoma of the Oral Cavity
- (2012) Marcelo dos Santos et al. PLoS One
- Prognostic value of HIF-1α expression during fractionated irradiation
- (2012) L. Helbig et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α
- (2011) Wenjing Su et al. CANCER LETTERS
- Exploratory Study of the Prognostic Value of Microenvironmental Parameters During Fractionated Irradiation in Human Squamous Cell Carcinoma Xenografts
- (2011) Ala Yaromina et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Activation of Hif1α by the Prolylhydroxylase Inhibitor Dimethyoxalyglycine Decreases Radiosensitivity
- (2011) Marina K. Ayrapetov et al. PLoS One
- HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention
- (2011) Elena Monti et al. Current Molecular Pharmacology
- HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression
- (2010) Jacqueline Kessler et al. BMC CANCER
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy
- (2009) H Harada et al. BRITISH JOURNAL OF CANCER
- NSC606985 induces apoptosis, exerts synergistic effects with cisplatin, and inhibits hypoxia-stabilized HIF-1α protein in human ovarian cancer cells
- (2009) Ning Zhang et al. CANCER LETTERS
- Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation
- (2009) Guido B. van den Broek et al. INTERNATIONAL JOURNAL OF CANCER
- Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts
- (2009) Ala Yaromina et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects
- (2009) D. L. Schwartz et al. MOLECULAR CANCER THERAPEUTICS
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- (2009) Jean-Pierre Pignon et al. RADIOTHERAPY AND ONCOLOGY
- Glycolytic metabolism and tumour response to fractionated irradiation
- (2009) Ulrike G.A. Sattler et al. RADIOTHERAPY AND ONCOLOGY
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- In vivo and in vitro effects of a HIF-1α inhibitor, RX-0047
- (2008) Z. Gunnur Dikmen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started